About Bardavon Health Innovations
Bardavon Health Innovations is a private company based in Overland Park, Kansas. It has reported $139,455,840 raised in six offerings on Form D since October 2015. Its chief executive is Alex Benson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | May 10, 2024 | $5,220,032of $15.6M target | 13 | $401K | EquityRule 506(b) | Form D ↗ |
| Oct 20, 2021 | Nov 2, 2021 | $106,695,156fully sold | 25 | $4.2M | EquityRule 506(b) | Form D ↗ |
| Mar 11, 2021 | Mar 23, 2021 | $6,661,190of $17.0M target | 10 | $666K | Debt, Options, Securities on exercise, Convertible Promissory Notes and Warrants.Rule 506(b) | Form D ↗ |
| Not yet | Dec 19, 2019 | $0target not set | 0 | — | Debt, Options, Securities on exercise, Convertible Promissory NoteRule 506(b) | Form D ↗ |
| Nov 9, 2018 | Nov 20, 2018 | $16,879,462of $24.3M target | 16 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Oct 8, 2015 | Oct 15, 2015 | $4,000,000of $8.0M target | 4 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $139,455,840 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bardavon Health Innovations's Form D filed May 10, 2024.
Earlier filings also listed Paul Morris (executive officer and director, last listed Mar 2023), Matthew Condon (executive officer and director, last listed Mar 2023), Matt Ferguson (director, last listed Mar 2023), Karan Takhar (director, last listed Mar 2023), Ed Enyeart (cfo, last listed Mar 2023), Thomas Jantsch (chief financial officer, last listed Mar 2021), James Rogers (chief marketing officer, last listed Mar 2021) and Dorothy Riviere (chief clinical officer, last listed Mar 2021).